Clinisys announces the acquisition of Orchard Software from Francisco Partners, a global investment firm that specialises in partnering with technology businesses.
The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to providing the laboratory informatics marketplace with cutting-edge software advancements.
The combined capabilities provide for comprehensive, flexible and scalable informatics offerings that can better serve customers across the global diagnostics market.
“Joining forces with Clinisys marks a powerful new chapter for Orchard,” said Billie Whitehurst, Orchard’s CEO.
“Our mission has always been to equip laboratorians with the tools they need to provide high-quality, efficient care. Clinisys shares that commitment and brings the global scale and innovation expertise needed to advance that mission even further.”
“We are excited to welcome Orchard to the Clinisys family,” said Michael Simpson, Clinisys’s CEO. “As we continue to pursue excellence in developing both our world-class solutions and our industry expertise, expanding with Orchard’s proven solution in the physician office, reference, and veterinary laboratory space was a clear decision for us."
"Together, we can better serve the entire spectrum of lab and diagnostic customers by enabling healthier and safer communities worldwide.”
Francisco Partners acquired Orchard Software in 2019 and, since investing in the company, the firm has implemented a strategic transformation of the business, including modernising Orchard’s product suite, enhancing its cloud solutions, and strengthening its leadership team.
“We are incredibly proud to have partnered with Orchard and supported its growth story during the past few years,” said Anders Mikkelsen, Principal at Francisco Partners.
“We would like to thank Billie and the Orchard management team for their outstanding work to position the company for long-term success."
"Clinisys and Roper Technologies are the ideal strategic partners to support Orchard’s next growth chapter, and we look forward to seeing the company continue to thrive.”
The combination of Orchard’s LIS portfolio and Clinisys’s LIMS and diagnostic solutions creates new opportunities for customers across North America and international markets.